Unique ID issued by UMIN | UMIN000024171 |
---|---|
Receipt number | R000023451 |
Scientific Title | The study on renal excretion drug dosage adjustment by point of care test in community pharmacy |
Date of disclosure of the study information | 2016/10/01 |
Last modified on | 2019/04/01 10:40:19 |
The study on renal excretion drug dosage adjustment by point of care test in community pharmacy
The study on proper use of medicine by point of care test in community pharmacy
The study on renal excretion drug dosage adjustment by point of care test in community pharmacy
The study on proper use of medicine by point of care test in community pharmacy
Japan |
Herpes zoster, Chronic Kidney disease
Medicine in general | Nephrology | Geriatrics |
Dermatology |
Others
NO
Pharmacokinetics are often altered in CKD patients.In particular, the optimal dosages of renally excreted drugs are strongly affected by renal impairment. Dosages that do not take renal function into account are a major cause of increases in drug blood concentrations that lead to adverse drug events. Appropriate dosages of renally excreted drugs can be calculated on the basis of renal function using creatinine clearance. Thus, dosage adjustment based on renal function contributes to a reduction in the incidence of adverse drug events in older patients and others with renal impairment. Adjustment of the drug dosage according to renal function (ADDR) by pharmacists, as a result of checking renal function and recommending alterations in their prescriptions, can prevent inappropriate dosages and thus reduce the incidence of the resulting adverse drug events.
However, there is insufficient implementation of ADDR by community pharmacists and to check prescriptions for patients with renal impairment and to implement ADDR.
In particular,most community pharmacists indicated that the most frequent obstacle to implementing ADDR was "Difficulty in obtaining information on patient renal function".
The aims of this study were to investigate the efficacy of renal function point of care testing for prevention of renally excreted drugs overdose.
Efficacy
The number of avoidance of renally excreted drugs overdose
Reduction of drug cost
Frequency of adverse drug event
Interventional
Single arm
Non-randomized
Open -no one is blinded
Self control
1
Prevention
Medicine | Other |
Serum creatinine point of care testing
20 | years-old | <= |
Not applicable |
Male and Female
The patients over 65 and/or had suspection of renal insufficiency
The patients are prescribed aciclovir, valaciclovir, or famciclovir
Dialysis patient
The patients taking anticoagulants
The patients are prone to bleeding
The patients who are unable to self-collect the blood sample
100
1st name | |
Middle name | |
Last name | Yuki Kondo |
Graduate School of Pharmaceutical Sciences, Kumamoto University
Department of Clinical Chemistry and Informatics
5-1 Oe-honmachi, Chuo-ku, Kumamoto, Japan
096-371-4559
ykondo@kumamoto-u.ac.jp
1st name | |
Middle name | |
Last name | Yuki Kondo |
Graduate School of Pharmaceutical Sciences, Kumamoto University
Department of Clinical Chemistry and Informatics
5-1 Oe-honmachi, Chuo-ku, Kumamoto, Japan
096-371-4559
ykondo@kumamoto-u.ac.jp
Kumamoto University
Kumamoto University
Other
Takuma central pharmacy
NO
託麻中央薬局(熊本県)
2016 | Year | 10 | Month | 01 | Day |
Unpublished
Completed
2016 | Year | 04 | Month | 01 | Day |
2015 | Year | 11 | Month | 26 | Day |
2016 | Year | 10 | Month | 01 | Day |
2019 | Year | 04 | Month | 01 | Day |
2016 | Year | 09 | Month | 26 | Day |
2019 | Year | 04 | Month | 01 | Day |
Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000023451
Research Plan | |
---|---|
Registered date | File name |
Research case data specifications | |
---|---|
Registered date | File name |
Research case data | |
---|---|
Registered date | File name |